Back to Trades
Sell4
GILEAD SCIENCES, INC.
GILD
Total Value
$6.7M
Net $3.3M sold
Sales
$3.3M
6 transactions
Company Information
- Company Name
- GILEAD SCIENCES, INC.
- Ticker Symbol
- GILD
- CIK
- 0000882095
Insider Information
- Name
- Mercier Johanna
- Role
- Chief Commercial Officer
- Location
- FOSTER CITY, CA
Officer
Filing Details
- Filing Date
- Aug 18, 2025
- Transaction Date
- Aug 15, 2025
- Accession Number
- 0000882095-25-000037
- Form Type
- 4
- Net Trading Amount
- -$3.3M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 15, 2025 | Common Stock | 11,800 | $66.64 | Exercise | $786.4K |
| Aug 15, 2025 | Common Stock | 11,800 | $118.50 | Sale | $1.4M |
| Aug 15, 2025 | Common Stock | 700 | $66.64 | Exercise | $46.6K |
| Aug 15, 2025 | Common Stock | 700 | $118.97 | Sale | $83.3K |
| Aug 15, 2025 | Common Stock | 11,800 | $66.64 | Exercise | $786.4K |
| Aug 15, 2025 | Common Stock | 11,800 | $118.51 | Sale | $1.4M |
| Aug 15, 2025 | Common Stock | 700 | $66.64 | Exercise | $46.6K |
| Aug 15, 2025 | Common Stock | 700 | $118.97 | Sale | $83.3K |
| Aug 15, 2025 | Common Stock | 2,800 | $118.51 | Sale | $331.8K |
| Aug 15, 2025 | Common Stock | 200 | $118.97 | Sale | $23.8K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Aug 15, 2025 | Derivative | 11,800 | $66.64 | Exercise | $786.4K |
| Aug 15, 2025 | Derivative | 700 | $66.64 | Exercise | $46.6K |
| Aug 15, 2025 | Derivative | 11,800 | $66.64 | Exercise | $786.4K |
| Aug 15, 2025 | Derivative | 700 | $66.64 | Exercise | $46.6K |
Footnotes
- (F1)The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- (F2)Sales prices for the transactions reported here range from $117.91 to $118.89. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- (F3)Sales prices for the transactions reported here range from $118.91 to $119.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or the shareowners upon request.
- (F4)Sales prices for the transactions reported here range from $117.91 to $118.85. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- (F5)Sales prices for the transactions reported here range from $118.95 to $118.98. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- (F6)The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.